Retrospective case-control study compares asprosin levels in endometrial hyperplasia and adenocarcinoma, suggesting potential implications for cancer mechanisms.
It has been demonstrated that asprosin, a glucogenic adipokine released by white adipose tissue, contributes to the pathophysiology of cancer and disorders associated with it. The aim of this study was to compare the immunoreactivity of asprosin in grade I endometrial adenocarcinoma and in endometrial hyperplasia (EH) with and without atypia.
No takes yet. Share an insight, caveat, or question.
ŞENOCAK et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: